← Open Payments lookup

SARABJOT KAUR: Open Payments

NPI 1700282761 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$478 in 16 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $68 · 2025 $478

Food & beverage: $478
CompanyPaymentsAmount
REVANCE THERAPEUTICS, INC.1$143
Otsuka America Pharmaceutical, Inc.3$67
Novo Nordisk Inc3$58
Alexion Pharmaceuticals, Inc.2$46
ARGENX US, INC.1$33
Neurocrine BioSciences, Inc.1$27
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$24
Boston Scientific Corporation1$23
SK Life Science, Inc.1$22
Indivior Inc.1$18

Products named: DAXXIFY, REXULTI, ULTOMIRIS, Ozempic, VYVGART, INGREZZA, CAPLYTA, WATCHMAN FLX.

Industry payments across IN — which companies pay providers there.